Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
Figure 1
Of 525 eligible patients, 477 (91%) were included in the study. 287 patients were enrolled during the initial baseline phase (Xpert MTB/RIF results not provided to clinicians during this validation phase) and 190 were enrolled during the implementation phase (Xpert MTB/RIF results provided to clinicians and used for patient management). Eighteen patients (nine in the baseline phase and nine in the implementation phase) died within three days of admission and were not included in survival analysis.